** Dental implant maker Straumann STMN.S falls 4% after the U.S. imposed 50% tariffs on Brazil and peer Align Technology ALGN.O cut its outlook and missed Q2 results expectations
** Straumann produces some of its value implants in Brazil, which means it is "likely to be impacted by these high tariffs," Sibylle Bischofberger, analyst at Vontobel, says
** Neodent value implants account for around 5% of total sales, but Straumann said relocation of production to the U.S. should be possible, Bischofberger adds
** Align cut its forecast for 2025, expecting revenue growth to be flat compared to 2024, compared to its previous guidance range of 3.5% to 5.5%
** It also reported revenue of $1.01 billion, missing analysts' estimate of $1.06 billion, according to LSEG data
** "Overall, the news is slightly negative," Bischofberger says
** Shares were down 4.68% at 0705 GMT; up to the previous session's close, shares down 6.5% YTD
(Reporting by Isabel Demetz)
((Isabel.demetz@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。